Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma

被引:70
|
作者
Wright, Abigail [1 ]
Wijeratne, Aruni [1 ]
Hung, Tracy [1 ]
Gao, Wei [2 ]
Whittaker, Sean [1 ,2 ]
Morris, Steven [1 ]
Scarisbrick, Julia [1 ]
Beynon, Teresa [1 ]
机构
[1] St Thomas Hosp, London SE1 7EH, England
[2] Kings Coll London, Kings Hlth Partners, London WC2R 2LS, England
关键词
Pruritus; itch; cutaneous T-cell lymphoma; CTCL; Skindex-29; quality of life; palliative care; MYCOSIS-FUNGOIDES; INTERNATIONAL-SOCIETY; PROGNOSTIC-FACTORS; SEZARY-SYNDROME; ORGANIZATION; SURVIVAL; PROPOSAL; OUTCOMES;
D O I
10.1016/j.jpainsymman.2012.01.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom burden. Pruritus appears to be one of the most prominent and disturbing symptoms. Objectives. To describe the prevalence and severity of pruritus and quality of life (QOL) in patients with CTCL. Methods. Patients with CTCL able to complete two questionnaires were invited to complete a visual analogue scale for itch (VAS(itch)) and the Skindex-29. Prevalence of pruritus, mean score, and SD were estimated for the VAS(itch) and Skindex-29, and the Pearson's correlation coefficient was calculated to evaluate the relationship between severity of pruritus and QOL. Results. One hundred patients were recruited (mean [SD] age 57.9 [12.9] years, range 30-86 years). Eighty-eight percent reported pruritus in the preceding four weeks, 46% indicating that it was often or always a problem. The mean (SD) of VAS(itch) (n = 92) was 3.2 (3.2), range zero to 10. The mean (SD) total Skindex-29 score was 43.3 (27.7). More advanced disease stage was associated with poorer QOL. The Skindex-29 correlated strongly with the VAS(itch) (Pearson's correlation coefficient = 0.72, P < 0.001). Conclusion. All aspects of QOL are affected in CTCL. Pruritus is a common and troublesome symptom. A more advanced disease stage and more severe pruritus symptoms were associated with poorer QOL in this study. J Pain Symptom Manage 2013;45:114-119. (C) 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [41] Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia
    Lee, Yong-Pyo
    Yoon, Sang Eun
    Song, Yuqin
    Kim, Seok Jin
    Yoon, Dok Hyun
    Chen, Tsai-Yun
    Koh, Young Il
    Kang, Ka Won
    Lee, Ho Sup
    Wei, Kevin Tay Kuang
    Lim, Soon Thye
    Poon, Michelle
    Irawan, Cosphiadi
    Zhao, Weili
    Do, Young Rok
    Lee, Mark Hong
    Ng, Soo Chin
    Lee, Won-Sik
    Guo, Ye
    Zhang, Huilai
    Kang, Hye-Jin
    Yun, Hwan Jung
    Kim, Hyo Jung
    Lung, Daryl Tan Chen
    Kwak, Jae-Yong
    Han, Jae Joon
    Mun, Yeung-Chul
    Oh, Sung Yong
    Shim, Hyeok
    Kwon, Jung Hye
    Sohn, Byeong Seok
    Park, Seong Kyu
    Jo, Jae Cheol
    Ko, Young Hyeh
    Jun, Zhu
    Kim, Won Seog
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (03) : 355 - 362
  • [42] Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma
    Yumeen, Sara
    Girardi, Michael
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 2020, 93 (01) : 111 - 121
  • [43] T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
    Marks, Jennifer A.
    Switchenko, Jeffrey M.
    Martini, Dylan J.
    Tarabadkar, Erica S.
    Khan, Mohammad K.
    Lechowicz, Mary Jo
    Allen, Pamela B.
    JAMA DERMATOLOGY, 2021, 157 (08) : 954 - 962
  • [44] Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma
    Vandersee, Staffan
    Humme, Daniel
    Terhorst, Dorothea
    Almohamad, Anis
    Moebs, Markus
    Beyer, Marc
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (01): : 30 - 36
  • [45] Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sezary syndrome
    Evans, Katherine G.
    Troxel, Andrea B.
    DeNardo, Barbara J.
    Introcaso, Camille E.
    Rook, Alain H.
    Kim, Ellen J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (04) : 682 - 689
  • [46] Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients
    Emge, Drew A.
    Bassett, Roland L.
    Duvic, Madeleine
    Huen, Auris O.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2020, 312 (04) : 283 - 288
  • [47] Advances in the pharmacological management of cutaneous T-cell lymphoma
    Roccuzzo, Gabriele
    Roggo, Andrea
    Ramelyte, Egle
    Marchisio, Sara
    Astrua, Chiara
    Ribero, Simone
    Scarisbrick, Julia
    Fava, Paolo
    Quaglino, Pietro
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, : 885 - 894
  • [48] Update on T-Cell Lymphoma Epidemiology
    Chen, Jane J.
    Tokumori, Franco Castillo
    Del Guzzo, Christina
    Kim, Jeanyoung
    Ruan, Jia
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2024, 19 (03) : 93 - 103
  • [49] Emerging drugs for the treatment of cutaneous T-cell lymphoma
    Cheng, Melissa
    Zain, Jasmine
    Rosen, Steven T.
    Querfeld, Christiane
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (01) : 45 - 54
  • [50] Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma
    Van-de-Velde, Vanessa
    Zhou, Youwen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (03) : 319 - 327